Skip to content

Computerized Assessment for Patients With Cancer

Computerized Assessment for Patients With Cancer-ESRA-C II

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00852852
Acronym
ESRA-C_II
Enrollment
779
Registered
2009-02-27
Start date
2008-10-31
Completion date
2013-12-31
Last updated
2018-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

ESRA-C 2, computerized assessment

Brief summary

This research study will test a new online computer program for patients, the Electronic Self-Report Assessment-Cancer (ESRA-C 2). The program allows patients to report symptoms and quality of life issues and learn information about how to deal with these experiences. The computer program is being tested to see if it can improve communications between patients and their care team and if it can improve patients' experiences during and after treatment.

Detailed description

* This study includes two groups of participants: 1) Clinician Participants and 2) Patient Participants. * Patient participants will have already completed one ESRA-C 2 report, which is a usual report in the clinic. If they decide to participate in the study, that report will be used in the study as the first report (Timepoint 1). In addition, they will complete a second report (Timepoint 2) and two more reports (Timepoint 3 and 4). Timepoint 3 will be 6-8 weeks after the participants treatment begins; Timepoint 4 will be 2-4 weeks after their treatment ends. * The Timepoint 2 report will be within 24 hours before a clinic visit. The conversation between the patient participant and the health care providers will be audio recorded. * Half of the patient participants will also see additional information in the computer program. The patient participants that are in this group can complete as many more ESRA-C 2 reports as they wish and will be able to read additional information about managing symptoms and quality of life issues, view graphs of their reports, add journal entries, and share all their reports with caregivers. * Clinician Participants will be asked to report brief demographics (age group, gender, race/ethnicity, position). During clinic appointments, research staff will place a 3 by 5 audio-recorder in the exam room just prior to some of the participant's visits. Recordings will be de-identified before coding. * After these visits, a research staff member will ask the clinician participant to report briefly on their satisfaction in the visit. The participant can check their responses on a piece of paper or dictate them.

Interventions

BEHAVIORALElectronic Self-Report Assessment - Cancer (ESRA-C)

The Electronic Self-Report Assessment-Cancer (ESRA-C) is a program allowing patients to report symptoms and quality of life issues and learn information about how to deal with these experiences.

Sponsors

Fred Hutchinson Cancer Center
CollaboratorOTHER
University of Washington
CollaboratorOTHER
National Institute of Nursing Research (NINR)
CollaboratorNIH
Dana-Farber Cancer Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Eligible clinician participants (Inclusion): * Nurses, physicians, or physician assistants * Perform consults/exams in clinics that have implemented routine use of the ESRA-C 2 screening tool as a standard of care Eligible patient participants (Inclusion): * 18 years of age or older * Diagnosis of malignant disease * Plan to have treatment in a study clinic * Speak and read English at a 6th grade level or higher

Design outcomes

Primary

MeasureTime frame
Symptom burden and quality of life 2-4 weeks post treatment3 years

Secondary

MeasureTime frame
To assess the feasibility of delivering a patient oriented, patient-controlled ESRA-C directly to patients outside clinically settings.3 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 23, 2026